Development of a prognostic scoring system for chronic myeloid leukemia in blast phase.

Saved in:
Bibliographic Details
Title: Development of a prognostic scoring system for chronic myeloid leukemia in blast phase.
Authors: Lauseker M; Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Medizinische Fakultät, Ludwig-Maximilians-Universität München, Munich, Germany. lauseker@ibe.med.uni-muenchen.de., Sacha T; Jagiellonian University Medical College, Department of Hematology, Krakow, Poland., Klamova H; Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Yakoleva J; RM Gorbacheva Research Institute, Pavlov University, Saint Petersburg, Russia., Lomaia E; Research Department of Immuno-Oncology, Almazov National Medical Research Centre, Saint Petersburg, Russian Federation., Milojkovic D; Hammersmith Hospital, Imperial College NHS Trust, London, UK., Fabisch C; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany., Nicolini FE; Centre Léon Bérard, Hématology Department, Lyon, France.; CRCL INSERM U1052, Lyon, France., Olsson-Stromberg U; University Hospital Uppsala, Department of Hematology, Uppsala, Sweden., Zackova D; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic., Lewandowski K; Department of Hematology & Bone Marrow Transplantation, Poznań University of Medical Sciences, Poznań, Poland., Ernst P; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany., Castagnetti F; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy., Hirschbühl K; Hematology and Oncology, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Zupan I; Department of Haematology, University Medical Centre Ljubljana, Ljubljana, Slovenia.; Medical Faculty, University of Ljubljana, Ljubljana, Slovenia., Voskanyan A; Hematology Center after Prof. R. Yeolyan, Yerevan, Armenia., Gołos A; Hematooncology Department, Copernicus Memorial Hospital, Lodz, Poland., Frietsch JJ; Medizinischen Klinik und Poliklinik II, Uniklinikum Würzburg, Würzburg, Germany., Gil J; Oncology Centre of the Podkarpackie Province, Department of Hematooncology, Brzozow, Poland., Faber E; Department of Hemato-Oncology, University Hospital Olomouc, Faculty of Medicine and Dentistry, Palacky University in Olomouc, Olomouc, Czech Republic., Krause SW; Uniklinik Erlangen, Medizinische Klinik 5, Erlangen, Germany., Parry A; Centre Hospitalier Annecy Genevois, Annecy, France., Saussele S; III. Med. Klinik, Med. Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany., Heibl S; Abteilung für Innere Medizin IV, Klinikum Wels-Grieskirchen, Wels, Austria., Franke GN; University of Leipzig Medical Center, Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, Leipzig, Germany., Casado LF; Servicio de Hematología, Hospital General Universitario de Toledo, Toledo, Spain., Paczkowska E; Department of General Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland., Hebart H; Zentrum für Innere Medizin, Hämatologie/Onkologie, Stauferklinikum Schwäbisch-Gmünd, Mutlangen, Germany., Eder M; Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation, Medizinische Hochschule Hannover, Hannover, Germany., Anhut P; Onkologische Schwerpunktpraxis Anhut, Kronach, Germany., Trautmann-Grill K; Medizinische Klinik I, Universitätsklinikum Carl Gustav Carus, TU Dresden, Dresden, Germany., Szczepanek E; Jagiellonian University Medical College, Department of Hematology, Krakow, Poland., Südhoff T; Klinikum Passau, Klinik für Onkologie, Hämatologie und Palliativmedizin, Passau, Germany., Patkowska E; Hematology Department, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Kiani A; Medizinische Klinik IV, Klinikum Bayreuth GmbH, Bayreuth, and Comprehensive Cancer Center Erlangen-EMN, Bayreuth, Germany., Ernst T; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany., Apperley J; Centre for Haematology, Imperial College NHS Trust, London, UK., Mayer J; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic., Hochhaus A; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany., Pfirrmann M; Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Medizinische Fakultät, Ludwig-Maximilians-Universität München, Munich, Germany., Brioli A; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany. brioli.annamaria@mh-hannover.de.; Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation, Medizinische Hochschule Hannover, Hannover, Germany. brioli.annamaria@mh-hannover.de.; Klinik und Poliklinik für Innere Medizin C, Hämatologie und Onkologie, Universitätsmedizin Greifswald, Greifswald, Germany. brioli.annamaria@mh-hannover.de.
Source: Leukemia [Leukemia] 2026 Apr; Vol. 40 (4), pp. 751-758. Date of Electronic Publication: 2026 Feb 19.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5551
DOI:10.1038/s41375-026-02875-9